General Information of the m6A Target Gene (ID: M6ATAR00661)
Target Name Retrotransposon-derived protein PEG10 (PEG10)
Synonyms
Embryonal carcinoma differentiation-regulated protein; Mammalian retrotransposon-derived protein 2; Myelin expression factor 3-like protein 1; MEF3-like protein 1; Paternally expressed gene 10 protein; Retrotransposon gag domain-containing protein 3; Retrotransposon-derived gag-like polyprotein; Ty3/Gypsy-like protein
    Click to Show/Hide
Gene Name PEG10
Chromosomal Location 7q21.3
Function
Retrotransposon-derived protein that binds its own mRNA and self-assembles into virion-like capsids. Forms virion-like extracellular vesicles that encapsulate their own mRNA and are released from cells, enabling intercellular transfer of PEG10 mRNA. Binds its own mRNA in the 5'-UTR region, in the region near the boundary between the nucleocapsid (NC) and protease (PRO) coding sequences and in the beginning of the 3'-UTR region . Involved in placenta formation: required for trophoblast stem cells differentiation (By similarity). Involved at the immediate early stage of adipocyte differentiation (By similarity). Overexpressed in many cancers and enhances tumor progression: promotes cell proliferation by driving cell cycle progression from G0/G1. Enhances cancer progression by inhibiting the TGF-beta signaling, possibly via interaction with the TGF-beta receptor ACVRL1. May bind to the 5'-GCCTGTCTTT-3' DNA sequence of the MB1 domain in the myelin basic protein (MBP) promoter; additional evidences are however required to confirm this result (By similarity).
    Click to Show/Hide
Gene ID 23089
Uniprot ID
PEG10_HUMAN
HGNC ID
HGNC:14005
Ensembl Gene ID
ENSG00000242265
KEGG ID
hsa:23089
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
PEG10 can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) [READER]
Representative RNA-seq result indicating the expression of this target gene regulated by IGF2BP1
Cell Line ES-2 cell line Homo sapiens
Treatment: siIGF2BP1 ES-2 cells
Control: siControl ES-2 cells
GSE161087
Regulation
logFC: 1.77E+00
p-value: 9.40E-06
More Results Click to View More RNA-seq Results
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary IGF2BP1 expression increased in EC, and high expression of this protein correlated with poor prognosis. IGF2BP1 can recognize m6A sites in the 3'UTR of PEG10 mRNA and recruits PABPC1 to enhance Retrotransposon-derived protein PEG10 (PEG10) mRNA stability, which consequently promotes PEG10 protein expression.
Target Regulation Up regulation
Responsed Disease Endometrial cancer ICD-11: 2C76
In-vitro Model RL95-2 Endometrial adenosquamous carcinoma Homo sapiens CVCL_0505
KLE Endometrial adenocarcinoma Homo sapiens CVCL_1329
Ishikawa Endometrial adenocarcinoma Homo sapiens CVCL_2529
HEC-1-B Endometrial adenocarcinoma Homo sapiens CVCL_0294
HEC-1-A Endometrial adenocarcinoma Homo sapiens CVCL_0293
AN3-CA Endometrial adenocarcinoma Homo sapiens CVCL_0028
In-vivo Model Six-week-old, female SCID-Berge mice were purchased from Vitalriver. EC cells with IGF2BP1 overexpression or silencing or the appropriate controls (1×106) were injected into lower abdominal cavity of each mouse (n = 5 mice/group).
Endometrial cancer [ICD-11: 2C76]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary IGF2BP1 expression increased in EC, and high expression of this protein correlated with poor prognosis. IGF2BP1 can recognize m6A sites in the 3'UTR of PEG10 mRNA and recruits PABPC1 to enhance Retrotransposon-derived protein PEG10 (PEG10) mRNA stability, which consequently promotes PEG10 protein expression.
Responsed Disease Endometrial cancer [ICD-11: 2C76]
Target Regulator Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) READER
Target Regulation Up regulation
In-vitro Model RL95-2 Endometrial adenosquamous carcinoma Homo sapiens CVCL_0505
KLE Endometrial adenocarcinoma Homo sapiens CVCL_1329
Ishikawa Endometrial adenocarcinoma Homo sapiens CVCL_2529
HEC-1-B Endometrial adenocarcinoma Homo sapiens CVCL_0294
HEC-1-A Endometrial adenocarcinoma Homo sapiens CVCL_0293
AN3-CA Endometrial adenocarcinoma Homo sapiens CVCL_0028
In-vivo Model Six-week-old, female SCID-Berge mice were purchased from Vitalriver. EC cells with IGF2BP1 overexpression or silencing or the appropriate controls (1×106) were injected into lower abdominal cavity of each mouse (n = 5 mice/group).
References
Ref 1 IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression. Theranostics. 2021 Jan 1;11(3):1100-1114. doi: 10.7150/thno.49345. eCollection 2021.